Groupama Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166M Buy
327,868
+59,318
+22% +$28.5M 2.09% 12
2026
Q1
$132M Sell
268,550
-7,028
-3% -$3.81M 1.93% 14
2025
Q4
$160M Buy
275,578
+30,562
+12% +$17.3M 2.34% 11
2025
Q3
$119M Buy
245,016
+90,854
+59% +$42.3M 1.74% 15
2025
Q2
$62.9M Buy
154,162
+8,363
+6% +$3.5M 1.04% 22
2025
Q1
$72.9M Buy
145,799
+18,919
+15% +$10.2M 1.46% 19
2024
Q4
$65.8M Sell
126,880
-104,400
-45% -$57.4M 1.35% 20
2024
Q3
$56.3M Buy
231,280
+22,009
+11% +$13M 1.46% 20
2024
Q2
$57.9M Buy
209,271
+109,823
+110% +$62.9M 0.79% 31
2024
Q1
$61.9M Sell
99,448
-122,697
-55% -$68.9M 1.13% 22
2023
Q4
$59.6M Buy
+222,145
New +$108M 1.55% 13

Other funds holding TMO

Groupama Asset Management's TMO Position: Q2 2026 in Review

Groupama Asset Management increased its Thermo Fisher Scientific (TMO) stake by 22% in Q2 2026, buying an estimated $28.5M and bringing the position to 327,868 shares worth $166M. The position accounts for 2.09% of the portfolio, ranked #12.

Groupama Asset Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Groupama Asset Management held 327,868 shares of Thermo Fisher Scientific worth $166M as of Q2 2026.
  • Groupama Asset Management bought 59,318 Thermo Fisher Scientific shares in Q2 2026, an estimated $28.5M.
  • Thermo Fisher Scientific made up 2.09% of Groupama Asset Management's portfolio in Q2 2026, its #12 holding.
  • Groupama Asset Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.